Memantine in Adult Autism Spectrum Disorder

Not Applicable

Terminated

• Conditions: Pervasive Developmental Disorder NOS; Autism; Asperger's Disorder
• Interventions: Drug: Placebo; Drug: memantine

• Registration Number: NCT01078844
• Lead Sponsor: Johns Hopkins University

Brief Summary

The purpose of this study is to see if memantine is helpful in managing problematic symptoms in adults with autism, Asperger's disorder, or Pervasive Developmental Disorder not otherwise specified (NOS).

Detailed Description

Not available

Study Timeline

• Study Start: 2010-02
• Study First Submitted: 2010-03-01
• Study First Submitted QC: 2010-03-01
• Study First Posted: 2010-03-02
• Primary Completion: 2010-07
• Study Completion: 2010-07
• Results First Submitted: 2017-05-17
• Status Verified: 2017-06
• Results First Submitted QC: 2017-06-27
• Last Update Submitted: 2017-06-27
• Results First Posted: 2017-07-26
• Last Update Posted: 2017-07-26

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 4

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Placebo	Placebo	Treatment as usual plus placebo
memantine	memantine	Treatment as usual plus memantine

Primary Outcome Measures

Name	Time	Method
Clinical Global Impression-Scale(CGI-S)	12 weeks

Trial Locations

Locations (1)

Johns Hopkins Bayview; 🇺🇸 Baltimore, Maryland, United States